| human | Q5 |
| P6178 | Dimensions author ID | 01131651347.93 |
| P496 | ORCID iD | 0000-0003-4944-7789 |
| P2038 | ResearchGate profile ID | Janet_Olson3 |
| P108 | employer | Mayo Clinic | Q1130172 |
| P734 | family name | Olson | Q16880716 |
| Olson | Q16880716 | ||
| Olson | Q16880716 | ||
| P101 | field of work | breast cancer | Q128581 |
| P735 | given name | Janet | Q13553631 |
| Janet | Q13553631 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | female | Q6581072 |
| Q36016386 | 11q13 is a susceptibility locus for hormone receptor positive breast cancer |
| Q35871567 | 19p13.1 is a triple-negative-specific breast cancer susceptibility locus |
| Q36021406 | 7q21-rs6964587 and breast cancer risk: an extended case-control study by the Breast Cancer Association Consortium |
| Q37169873 | 9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium |
| Q36296879 | A Robust e-Epidemiology Tool in Phenotyping Heart Failure with Differentiation for Preserved and Reduced Ejection Fraction: the Electronic Medical Records and Genomics (eMERGE) Network |
| Q57250674 | A common coding variant in CASP8 is associated with breast cancer risk |
| Q35957063 | A comprehensive evaluation of interaction between genetic variants and use of menopausal hormone therapy on mammographic density |
| Q44971724 | A comprehensive examination of CYP19 variation and breast density |
| Q33844619 | A comprehensive examination of CYP19 variation and risk of breast cancer using two haplotype-tagging approaches |
| Q37192589 | A genome-wide association study to identify genetic susceptibility loci that modify ductal and lobular postmenopausal breast cancer risk associated with menopausal hormone therapy use: a two-stage design with replication |
| Q37619303 | A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium |
| Q92711687 | A network analysis to identify mediators of germline-driven differences in breast cancer prognosis |
| Q36790591 | A novel automated mammographic density measure and breast cancer risk |
| Q36857238 | A novel housing-based socioeconomic measure predicts hospitalisation and multiple chronic conditions in a community population |
| Q57305942 | A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer |
| Q37417780 | AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 study |
| Q61948755 | Abstract 3266: Expression quantitative trait locus analysis of triple negative breast cancer |
| Q91940202 | An assessment of patient perspectives on pharmacogenomics educational materials |
| Q36073563 | An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression |
| Q33641475 | Ancestry-shift refinement mapping of the C6orf97-ESR1 breast cancer susceptibility locus |
| Q35681656 | Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis |
| Q34613673 | Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study |
| Q93196132 | Assessing the stability of biobank donor preferences regarding sample use: evidence supporting the value of dynamic consent |
| Q35218520 | Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy |
| Q45979098 | Association analysis identifies 65 new breast cancer risk loci. |
| Q33828680 | Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival |
| Q55278933 | Association between an individual housing-based socioeconomic index and inconsistent self-reporting of health conditions: a prospective cohort study in the Mayo Clinic Biobank. |
| Q36592201 | Association of Arrhythmia-Related Genetic Variants With Phenotypes Documented in Electronic Medical Records |
| Q37292963 | Association of ESR1 gene tagging SNPs with breast cancer risk |
| Q28212542 | Association of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs with cancer incidence and mortality |
| Q45087578 | Association of family history of cervical, ovarian, and uterine cancer with histological categories of lung cancer: the Iowa Women's Health Study. |
| Q37268494 | Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry |
| Q34809698 | Association of genetic variation in genes implicated in the beta-catenin destruction complex with risk of breast cancer |
| Q37485135 | Association of genetic variation in mitotic kinases with breast cancer risk |
| Q35022847 | Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies |
| Q45117499 | Associations of general and abdominal obesity with multiple health outcomes in older women: the Iowa Women's Health Study |
| Q57056093 | Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis |
| Q36085073 | Automated discovery of drug treatment patterns for endocrine therapy of breast cancer within an electronic medical record |
| Q38914005 | BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer |
| Q37002955 | BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers |
| Q46115524 | Body mass index and breast cancer survival: a Mendelian randomization analysis |
| Q34327945 | Breast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2 |
| Q36841465 | Breast cancer risk reduction and membrane-bound catechol O-methyltransferase genetic polymorphisms |
| Q35940158 | Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170. |
| Q36449203 | CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer |
| Q34793437 | CYP2B6*6 is associated with increased breast cancer risk |
| Q38645783 | CYP2D6 phenotypes are associated with adverse outcomes related to opioid medications. |
| Q28385765 | Candidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk |
| Q34380497 | Centrosome-related genes, genetic variation, and risk of breast cancer |
| Q73798662 | Cigarette smoking increases risk for breast cancer in high-risk breast cancer families |
| Q92397645 | Cohort Profile: The Right Drug, Right Dose, Right Time: Using Genomic Data to Individualize Treatment Protocol (RIGHT Protocol) |
| Q90015302 | Colorectal cancer outcomes after screening with the multi-target stool DNA assay: protocol for a large-scale, prospective cohort study (the Voyage study) |
| Q94486442 | Combined associations of a polygenic risk score and classical risk factors with breast cancer risk |
| Q37368000 | Combined genetic and splicing analysis of BRCA1 c.[594-2A>C; 641A>G] highlights the relevance of naturally occurring in-frame transcripts for developing disease gene variant classification algorithms |
| Q35891162 | Common breast cancer susceptibility loci are associated with triple-negative breast cancer |
| Q34379032 | Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium |
| Q31082788 | Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) |
| Q34181322 | Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer |
| Q57278898 | Correction: Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) |
| Q37685729 | DNA mismatch repair gene MSH6 implicated in determining age at natural menopause |
| Q43646841 | Dietary folate intake, alcohol, and risk of breast cancer in a prospective study of postmenopausal women |
| Q61670397 | Differential Association of Body Mass Index and Fat Distribution with Three Major Histologic Types of Lung Cancer: Evidence from a Cohort of Older Women |
| Q77839315 | Does a family history of cancer increase the risk for postmenopausal endometrial carcinoma? A prospective cohort study and a nested case-control family study of older women |
| Q44797212 | Does folate intake decrease risk of postmenopausal breast cancer among women with a family history? |
| Q55110745 | E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium. |
| Q34334131 | ERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancer |
| Q34381496 | Effect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort study |
| Q36975149 | Epigenome-wide ovarian cancer analysis identifies a methylation profile differentiating clear-cell histology with epigenetic silencing of the HERG K+ channel |
| Q57250672 | Erratum: Corrigendum: A common coding variant in CASP8 is associated with breast cancer risk |
| Q46801210 | Estrogen bioactivation, genetic polymorphisms, and ovarian cancer |
| Q50119980 | Ethical Considerations Related to Return of Results from Genomic Medicine Projects: The eMERGE Network (Phase III) Experience. |
| Q89996790 | Evaluation of Germline Genetic Testing Criteria in a Hospital-Based Series of Women With Breast Cancer |
| Q36430014 | Evaluation of associations between common variation in mitotic regulatory pathways and risk of overall and high grade breast cancer |
| Q36918235 | Evaluation of the Aromatase Inhibition Potential of Freeze-Dried Grape Powder |
| Q35653910 | Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk |
| Q73800167 | Evidence for a major gene influence on abdominal fat distribution: the Minnesota Breast Cancer Family Study |
| Q36720821 | Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors |
| Q35064451 | Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation |
| Q37594336 | FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium |
| Q74045794 | Family histories of diabetes mellitus and breast cancer and incidence of postmenopausal breast cancer |
| Q37617882 | Fatty acids found in dairy, protein and unsaturated fatty acids are associated with risk of pancreatic cancer in a case-control study |
| Q53415457 | Fifty-year follow-up of cancer incidence in a historical cohort of Minnesota breast cancer families. |
| Q35524465 | Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2. |
| Q35063160 | Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk |
| Q39844032 | Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer |
| Q36248936 | Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk |
| Q34903062 | Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1. |
| Q37367871 | Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. |
| Q34979715 | Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium |
| Q36467889 | Fruit and vegetable consumption is inversely associated with having pancreatic cancer |
| Q36124728 | Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus |
| Q33589487 | Genes associated with histopathologic features of triple negative breast tumors predict molecular subtypes |
| Q37739048 | Genetic modifiers of CHEK2*1100delC-associated breast cancer risk |
| Q29417068 | Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction study |
| Q35925620 | Genetic predisposition to ductal carcinoma in situ of the breast |
| Q35179897 | Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study |
| Q34378972 | Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade |
| Q37311599 | Genetic variation in the chromosome 17q23 amplicon and breast cancer risk |
| Q30000080 | Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent |
| Q35996692 | Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer |
| Q24622610 | Genome-wide association studies identify four ER negative-specific breast cancer risk loci |
| Q29417100 | Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer |
| Q24645441 | Genome-wide association study identifies novel breast cancer susceptibility loci |
| Q35965983 | Health behaviors and quality of life predictors for risk of hospitalization in an electronic health record-linked biobank |
| Q36276540 | Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization |
| Q33330850 | Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics |
| Q36547888 | Heterogeneity of luminal breast cancer characterised by immunohistochemical expression of basal markers |
| Q44431949 | High-folate diets and breast cancer survival in a prospective cohort study |
| Q34119042 | Hospitalizations and emergency department use in Mayo Clinic Biobank participants within the employee and community health medical home |
| Q36062033 | Identification of a novel percent mammographic density locus at 12q24. |
| Q36859142 | Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer |
| Q34038964 | Identification of new genetic susceptibility loci for breast cancer through consideration of gene-environment interactions |
| Q36014067 | Identification of novel genetic markers of breast cancer survival |
| Q46103372 | Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer |
| Q114015275 | Implementation of preemptive DNA sequence–based pharmacogenomics testing across a large academic medical center: The Mayo-Baylor RIGHT 10K Study |
| Q36922297 | Improvement in Cardiovascular Risk Prediction with Electronic Health Records |
| Q37653051 | Increased risk of hospitalization for ultrarapid metabolizers of cytochrome P450 2D6 |
| Q40146207 | Individual housing-based socioeconomic status predicts risk of accidental falls among adults |
| Q95321974 | Inferring multimodal latent topics from electronic health records |
| Q33638923 | Inherited determinants of ovarian cancer survival |
| Q34996647 | Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer |
| Q35104068 | Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer |
| Q38870275 | Integrating Pharmacogenomics into Clinical Practice: Promise vs Reality |
| Q61670387 | Interaction of adolescent anthropometric characteristics and family history on breast cancer risk in a Historical Cohort Study of 426 families (USA) |
| Q44177120 | Interaction of dietary folate intake, alcohol, and risk of hormone receptor-defined breast cancer in a prospective study of postmenopausal women |
| Q43872668 | Interaction of waist/hip ratio and family history on the risk of hormone receptor-defined breast cancer in a prospective study of postmenopausal women |
| Q34898735 | Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors |
| Q64279327 | Joint association of mammographic density adjusted for age and body mass index and polygenic risk score with breast cancer risk |
| Q57191573 | Large-Scale Genomic Analyses Link Reproductive Aging to Hypothalamic Signaling, Breast Cancer Susceptibility, and BRCA1-Mediated DNA Repair |
| Q28267893 | Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair |
| Q36778183 | Mammographic breast density response to aromatase inhibition |
| Q36986209 | Meat-related mutagens and pancreatic cancer: null results from a clinic-based case-control study |
| Q33915396 | Methylation of leukocyte DNA and ovarian cancer: relationships with disease status and outcome |
| Q61670379 | Methylenetetrahydrofolate reductase haplotype tag single-nucleotide polymorphisms and risk of breast cancer. |
| Q34497352 | MicroRNA related polymorphisms and breast cancer risk |
| Q34123806 | Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls |
| Q37716307 | Multidisciplinary model to implement pharmacogenomics at the point of care. |
| Q36897003 | Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer |
| Q37356243 | Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. |
| Q30374367 | No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. |
| Q36393107 | No evidence for association of inherited variation in genes involved in mitosis and percent mammographic density |
| Q35752042 | Novel Associations between Common Breast Cancer Susceptibility Variants and Risk-Predicting Mammographic Density Measures |
| Q36960453 | Nutrients from fruit and vegetable consumption reduce the risk of pancreatic cancer |
| Q28584533 | PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS |
| Q36184231 | PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2. |
| Q33874771 | Participant-perceived understanding and perspectives on pharmacogenomics: the Mayo Clinic RIGHT protocol (Right Drug, Right Dose, Right Time) |
| Q36873786 | Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium |
| Q36727026 | Personalizing Aspirin Use for Targeted Breast Cancer Chemoprevention in Postmenopausal Women |
| Q62583133 | Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes |
| Q77839080 | Postmenopausal cancer risk after self-reported endometriosis diagnosis in the Iowa Women's Health Study |
| Q36583004 | Prediction of breast cancer risk based on profiling with common genetic variants |
| Q30572528 | Preemptive genotyping for personalized medicine: design of the right drug, right dose, right time-using genomic data to individualize treatment protocol |
| Q81497735 | Prepregnancy exposure to cigarette smoking and subsequent risk of postmenopausal breast cancer |
| Q55508030 | Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. |
| Q35814338 | Quantifying the importance of disease burden on perceived general health and depressive symptoms in patients within the Mayo Clinic Biobank |
| Q36009422 | RAD51B in Familial Breast Cancer |
| Q30436018 | Racial differences in primary central nervous system lymphoma incidence and survival rates |
| Q61670381 | Recreational Physical Activity and Risk of Postmenopausal Breast Cancer Based on Hormone Receptor Status |
| Q35155449 | Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia |
| Q36955678 | Relative weight at age 12 and risk of postmenopausal breast cancer |
| Q35170369 | Risk factors for meningioma in postmenopausal women: results from the Iowa Women's Health Study |
| Q73062975 | Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer |
| Q37300024 | Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042. |
| Q90589559 | Risk of serious infection among individuals with and without low count monoclonal B-cell lymphocytosis (MBL) |
| Q36545934 | SNP-SNP interaction analysis of NF-κB signaling pathway on breast cancer survival |
| Q33593016 | Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies |
| Q49817640 | The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity. |
| Q91178389 | The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer |
| Q34648736 | The Mayo Clinic Biobank: a building block for individualized medicine |
| Q35781316 | The SNP rs6500843 in 16p13.3 is associated with survival specifically among chemotherapy-treated breast cancer patients |
| Q50702620 | The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: a surveillance, epidemiology, and end results analysis. |
| Q36137764 | The contributions of breast density and common genetic variation to breast cancer risk |
| Q37064849 | The effect of grape seed extract on estrogen levels of postmenopausal women: a pilot study |
| Q36981617 | The influence of mammogram acquisition on the mammographic density and breast cancer association in the Mayo Mammography Health Study cohort |
| Q57265642 | The postmenopausal hormone replacement therapy-related breast cancer risk is decreased in women carrying the CYP2C19*17 variant |
| Q36142060 | The role of genetic breast cancer susceptibility variants as prognostic factors |
| Q37325069 | Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging |
| Q53414172 | Twinship and risk of postmenopausal breast cancer. |
| Q92994868 | Two truncating variants in FANCC and breast cancer risk |
| Q38987441 | Variability in assigning pathogenicity to incidental findings: insights from LDLR sequence linked to the electronic health record in 1013 individuals |
| Q33793932 | Variation in anastrozole metabolism and pharmacodynamics in women with early breast cancer |
| Q33636005 | Variation in genes required for normal mitosis and risk of breast cancer |
| Q34177267 | Xenobiotic-Metabolizing gene polymorphisms and ovarian cancer risk |
Search more.